Immunotherapy: Moving beyond PD1 and PDL1 inhibitors

preview_player
Показать описание

In this presentation from the 22nd Annual Perspectives in Thoracic Oncology, Dr. Vassiliki A. Papadimitrakopoulou discusses immunotherapy in lung cancer beyond PDF1 and PDL1 inhibitors.

© 2017 Imedex, LLC.
Рекомендации по теме